Kiniksa Pharmaceuticals International, plc
Equities
KNSA
GB00BRXB0C07
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.36 USD | +1.36% |
|
+3.70% | +10.38% |
07-01 | Kiniksa Pharmaceuticals Files $400 Million Mixed Shelf | MT |
07-01 | Kiniksa Pharmaceuticals International, plc(NasdaqGS:KNSA) dropped from Russell Small Cap Comp Value Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.38% | 1.38B | |
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.6B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |
- Stock Market
- Equities
- KNSA Stock
- News Kiniksa Pharmaceuticals International, plc
- Kiniksa Pharmaceuticals, Ltd. Appoints Richard S. Levy to Board